Etomoxir
Etomoxir ((R)-(+)-Etomoxir) is an irreversible, small-molecule inhibitor of carnitine palmitoyl-transferase 1a (CPT1a). It inhibits fatty acid oxidation (FAO) and may have potential in treating diabetes, inflammation, cancer and cardiac metabolic diseases.
| Trivial name | (R)-(+)-Etomoxir |
| Catalog Number | E4787 |
| Molecular Formula | C24H23FN4O3 |
| CAS# | 124083-20-1 |
| Inchi | InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30) |
| Inchi Key | FDLYAMZZIXQODN-UHFFFAOYSA-N |
| SMILES | C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/etomoxir.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E4787-Etomoxir-chemical-structure.png |